BREAKING
Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 7 hours ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 9 hours ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 10 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 22 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 22 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 1 day ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 1 day ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 1 day ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 1 day ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 1 day ago Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 7 hours ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 9 hours ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 10 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 22 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 22 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 1 day ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 1 day ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 1 day ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 1 day ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 1 day ago
ADVERTISEMENT
Market News

Weakness in beer sales creeps into Anheuser Busch InBev Q3 earnings, stock tanks

Hurt by weakness in beer sales in China and the US, brewing giant Anheuser Busch InBev (NYSE:BUD) aka AB InBev reported third-quarter revenues and earnings that missed Wall Street expectations. BUD shares tanked 8.5% during pre-market hours on Friday. BUD shares have increased 38% in the year-to-date period. The Belgian firm reported a modest 2.7% […]

October 25, 2019 2 min read

Hurt by weakness in beer sales in China and the US, brewing giant Anheuser Busch InBev (NYSE:BUD) aka AB InBev reported third-quarter revenues and earnings that missed Wall Street expectations. BUD shares tanked 8.5% during pre-market hours on Friday.

BUD shares have increased 38% in the year-to-date period.

ab inbev earnings
CREDIT: Blake Guidry/Unsplash)

The Belgian firm reported a modest 2.7% growth in revenues to $13.17 billion, which fell short of the street consensus of $13.82 billion. Adjusted net income of $1.22 per share was, meanwhile, 9 cents short of the analysts’ target.

There has been a change in consumer preferences towards healthier drinks, primarily in the US, hurting sales of soda and beer. The world’s largest brewer was forced to buy up numerous craft brewers over the past few years to maintain its market position in the beer industry.

ADVERTISEMENT

READ: Coca-Cola beats Q3 revenue expectations; EPS comes in line

The downbeat results and possibility of prolonged weakness has forced the company to step down its expectation for the full year. The parent of Budweiser and Corona beer now sees “moderate” EBITDA growth in FY19, compared to earlier projection of “strong” growth.

“Price increases implemented in South Korea and Brazil drove volume declines, which were exacerbated by softer consumer demand in light of difficult macroeconomic conditions,” the company said in a statement.

Earlier this month, rival firm Constellation Brands (NYSE: STZ) reported mixed quarterly results. The stock, however, fell as the company incurred a bigger loss from investments in cannabis firm Canopy Growth Corporation (GCG).

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

ADVERTISEMENT
ADVERTISEMENT